MINIMAL CHANGE DISEASE (MCD)
Clinical trials for MINIMAL CHANGE DISEASE (MCD) explained in plain language.
Never miss a new study
Get alerted when new MINIMAL CHANGE DISEASE (MCD) trials appear
Sign up with your email to follow new studies for MINIMAL CHANGE DISEASE (MCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to plug protein leak in kidney patients
Disease control Recruiting nowThis study tests an experimental drug called EVER001 in 45 adults with three types of kidney disease (FSGS, MCD, or IgA nephropathy) that cause protein to leak into urine. Participants take the drug twice daily for a year. The main goal is to see if it safely reduces protein leve…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Phase: PHASE2 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to stop kidney disease relapses
Disease control Recruiting nowThis study tests a drug called BAT4406F in people with two rare kidney conditions: Minimal Change Disease and Focal Segmental Glomerulosclerosis. The goal is to see if it can reduce protein in the urine and prevent the disease from coming back. About 192 participants will receive…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Kidney disease mystery: scientists launch massive data hunt
Knowledge-focused Recruiting nowThis study is for people with rare kidney diseases like Minimal Change Disease, Focal Segmental Glomerulosclerosis, and Membranous Nephropathy. Researchers will collect health information and biological samples from 1,200 participants over many years. The goal is to better unders…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC